ARTICLE: Spectral Flow Cytometry in CAR T-Cell Clinical Trials: Enabling Novel Therapies
Monitoring CAR T-cells post-infusion in clinical trials using flow cytometry requires a robust, standardized assay to generate valuable and reliable data for therapy monitoring and biomarker identification.
